Adult Myelodysplastic Syndrome

Myelodysplastic syndromes are typically diseases of older adults. Patients in whom the onset is early may have distinct molecular… (More)

BACKGROUND Myelodysplastic syndrome (MDS), a disorder of clonal hematopoiesis, is an important clinical entity, but most of the… (More)

BACKGROUND Immunophenotyping of bone marrow (BM) hemopoietic precursors is useful for diagnosis of adult myelodysplastic syndrome… (More)

AF1Q, a mixed lineage leukemia gene fusion partner, is identified as a poor prognostic biomarker for pediatric acute myeloid… (More)

MLLT11, an MLL fusion partner, is a poor prognostic biomarker for paediatric acute myeloid leukaemia (AML), adult normal… (More)

OBJECTIVE Myelodysplastic syndrome (MDS) is recognized as a preleukemic disorder with a variable risk of transformation to acute… (More)

Thirty-five adult myelodysplastic syndrome (MDS) patients were included in this study: 11 refractory anemia (RA), 4 RA with ring… (More)

Although allogeneic stem cell transplantation from a human leukocyte antigen (HLA)-identical related donor offers a potential… (More)

A new classification of myelodysplastic and myeloproliferative diseases in childhood has greatly facilitated the diagnosis of… (More)

Myelodysplastic syndromes (MDS) are clonal haematopoietic stem cell disorders characterised by ineffective and dyspoietic… (More)